Spravato® Treatment for Depression at Mind Body Seven
What Is Spravato®?
A New Option for Treatment-Resistant Depression
Spravato® (esketamine) is a groundbreaking treatment approved by the FDA specifically for adults with treatment-resistant depression. This innovative solution offers hope to individuals who haven’t experienced relief from traditional antidepressants.
How Spravato® Works
Spravato® is an NMDA receptor antagonist, which sets it apart from traditional antidepressants that primarily target serotonin, dopamine, or norepinephrine pathways.
While esketamine is derived from ketamine, they are not the same. Spravato® is carefully formulated for medical use and is FDA-approved for treatment-resistant depression. This distinction ensures its safety and efficacy when administered under professional supervision.
Is Spravato® Right for You?
Who Qualifies for This Treatment
Spravato® is ideal if you’ve tried multiple antidepressants without finding relief. A consultation at Mind Body Seven will determine if this treatment is suitable for your needs.
How to Get Started
Take the first step by scheduling a consultation with our psychiatric team. We’ll help you explore whether Spravato® aligns with your treatment goals.
Take the First Step Toward Relief
Book a Spravato® Consultation
Don’t wait any longer to find relief. Schedule your Spravato® consultation today through our website or call our friendly team. Your path to better mental health begins at Mind Body Seven.
Why Choose Spravato® at Mind Body Seven?
-
Comprehensive Psychiatric Evaluation and Oversight
At Mind Body Seven, every patient begins with a thorough psychiatric evaluation. This initial consultation helps determine if Spravato® is the right fit for your unique needs. Only eligible patients proceed to treatment, ensuring the best outcomes and safety.
-
Safe, Monitored Administration in a Supportive Setting
Spravato® treatment at Mind Body Seven involves in-clinic dosing, where patients are closely monitored by our team. Each session allows time for post-treatment recovery, ensuring you leave feeling supported and secure.
-
Integrated Mental Health Support
Spravato® isn’t a standalone treatment at Mind Body Seven. We integrate it with psychotherapy, wellness coaching, and medication management to promote long-lasting mental health improvements tailored to your situation.
What to Expect During Spravato® Treatment
-
Initial Dosing and Observation Protocol
Spravato® is administered as a nasal spray in a controlled clinical setting. Sessions typically last around two hours, during which safety and symptom responses are carefully monitored.
-
Treatment Schedule
The treatment usually begins with twice-weekly sessions that taper down as you progress. This schedule supports gradual improvement while allowing your care team to continuously evaluate and adapt your plan.
-
Follow-Up Care
At Mind Body Seven, your progress is a priority. After each session, we assess symptom relief and adjust your treatment as needed, ensuring you receive the most benefit from Spravato®.
Important Safety Information and Limitations
Not for Use as an Anesthetic or Pain Reliever
Spravato® is specifically approved for treatment-resistant depression and not for other off-label uses, such as anesthesia or pain relief.
Not a Crisis Intervention or Suicide Prevention Treatment
This treatment is not suited for addressing immediate crises or acute suicidal ideation. If you or a loved one are in crisis, please seek emergency assistance immediately.
Not Approved for Use in Children
Per FDA guidelines, Spravato® is only approved for adults and should not be used in patients under 18 years old.
Esketamine vs Ketamine : What’s the Difference?
FDA-Approved vs Off-Label Use
Unlike ketamine, which is often used off-label for depression, Spravato® has undergone rigorous FDA evaluation, ensuring its safety and effectiveness for treatment-resistant depression.
Safety, Dosing, and Clinical Oversight
Spravato® dosing occurs in a carefully controlled medical environment. This ensures precise administration and professional monitoring, significantly differentiating it from off-label ketamine treatments.